Instructions for use of the antiviral drug Valganciclovir in pediatric patients

1. Drug Introduction

Valganciclovir (Valganciclovir) is an oral prodrug that is converted into galciclovir (Ganciclovir) in the body and is mainly used to prevent and treat cytomegalovirus (CMV) infection. CMVInfection is more common in immunocompromised patients, especially in organ transplant recipients and patients with AIDS. In recent years, valganciclovir (valganciclovir) has also been increasingly used in pediatric patients, especially those at high risk or already infected with CMV.

2. Indications

Valganciclovir is suitable for pediatric patients with the following conditions:

CongenitalCMVInfection: More common in newborns and infants, it may cause hearing, vision and nervous system damage.

CMVPrevention after organ transplantation: Pediatric organ transplant patients face a higher risk of CMV infection due to immunosuppressive treatment.

Prevention and treatment of CMV in children with immunodeficiency: including children with AIDS and other children with low immune function due to disease or treatment.

3. Medicine use

The dosage and regimen of Valganciclovir varies based on the child's weight, age and specific medical condition.

3.1 Congenital CMVinfection: For infants 4 weeks old, the recommended dose is 16 mg/kg twice daily for 6 months.

Prevention of CMV after organ transplantationFor children whose weight≥10 kg, the recommended dose is once a day, and each dose is calculated based on body weight as follows:

10-14 kg：150 mg

15-20 kg：200 mg

21-24 kg：250 mg

25-29 kg：300 mg

≥30 kg：450 mg

Treatment of infected CMV: Acute treatment period (14-21 days), twice daily, each dose is calculated based on body weight. During the maintenance treatment period, the dose is adjusted based on clinical response and viral load, generally once daily.

3.2 Dose adjustment: During the use of valganciclovir (valganciclovir) in pediatric patients, the dose may need to be adjusted based on renal function and hematological parameters. Conduct regular blood tests and kidney function monitoring to ensure that medications are used within a safe range.

4. Notes

4.1 Monitoring

Hematology monitoring: Check blood routine regularly, including white blood cell count, neutrophil count and platelet count. Myelosuppression isVansevir (valganciclovir)One of the common side effects, especially with long-term use or high doses.

Renal function monitoring: SinceVansevir (valganciclovir) is excreted through the kidneys, serum creatinine and glomerular filtration rate (GFR) need to be checked regularly and the dose adjusted if necessary.

4.2 Contraindications

Patients with known hypersensitivity to galcyclovir orvalganciclovir : Avoid use to prevent allergic reaction.

Patients with severe renal insufficiency: Use with caution and dose adjustment if necessary.

4.3 Special groups

Pregnant and Nursing Women: Although this section is not directly relevant to pediatric patients, understandingthe potential risks of valganciclovir (valganciclovir) to the mother and fetus can be helpful in family decision-making. Due to the teratogenic potential of valganciclovir, Valganciclovir is not recommended for use in pregnant and lactating women.

5. Side effects

Common side effects of Valganciclovir in children include:

Myelosuppression: such as leukopenia, thrombocytopenia and anemia. Hematological parameters should be monitored regularly.

Gastrointestinal reactions: such as nausea, vomiting, and diarrhea. You usually get used to it gradually during the course of taking it. If the symptoms are severe, you need to consult a doctor.

Renal Impairment: Renal function needs to be monitored closely, especially in patients with renal insufficiency.

A small number of patients may experience the following serious side effects and need to stop taking the drug immediately and seek medical attention:

Severe allergic reaction: such as rash, itching, trouble breathing, swelling of face or throat.

Acute renal failure: manifested by decreased urine output, increased blood pressure, fatigue, and nausea.

6. Medication guidance

6.1 How to take medicine

Taking after meals: To reduce gastrointestinal discomfort, it is recommended to take valganciclovir after meals.

Take medicine on time: Take it at the same time every day to maintain stable blood concentration.

6.2 Forgot to take medicine

Take it as soon as possible: If you forget to take your medicine, you should take it as soon as possible. If it is near the time of your next dose, skip the missed dose and continue taking your medication at your normal time. Do not take a double dose at one time.

6.3 Withdrawal

Discontinue medication as directed by your doctor: Do not discontinue medication or adjust dosage without authorization. Discontinuation of medication or adjustment of dosage should be done under the guidance of a doctor.

7. Drug Storage

Room temperature storage: Store medications at room temperature below 25°C, away from direct sunlight and moisture.

Keep away from children: Keep medicine out of reach of children to prevent accidental ingestion.

8. Drug interactions

Valganciclovir may interact with other medications, affecting efficacy or increasing the risk of side effects. Common interactions include:

With other antiviral drugs: such as zidovudine, there may be an increased risk of myelosuppression.

With immunosuppressants: such as cyclosporine or tacrolimus, may increase the risk of kidney damage.

Valganciclovir (valganciclovir) has shown promising efficacy in the treatment and prevention ofCMVinfection in pediatric patients. Due to the special physical condition and medication needs of children, treatment plans should be carried out under the guidance of professional doctors to ensure safety and effectiveness. By regularly monitoring blood and kidney function and rationally adjusting the dose, the side effects of Valganciclovir can be effectively managed to ensure smooth treatment. Parents should strictly follow the doctor's instructions to take medicines for their children, and pay attention to the storage and safe use of medicines to ensure the health and safety of their children.